Abstract:Background and PurposeAtherosclerosis is a chronic inflammatory disease, in which vulnerable plaques' have been recognized as the underlying risk factor for coronary disease. Regulator of G-protein signalling (RGS) 5 controls endothelial cell function and inflammation. In this study, we explored the effect of RGS5 on atherosclerosis and the potential underlying mechanisms. Experimental ApproachRGS5(-/-) apolipoprotein E (ApoE)(-/-) and ApoE(-/-) littermates were fed a high-fat diet for 28 weeks. Total aorta surface and lipid accumulation were measured by Oil Red O staining and haematoxylin-eosin staining was used to analyse the morphology of atherosclerotic lesions. Inflammatory cell infiltration and general inflammatory mediators were examined by immunofluorescence staining. Apoptotic endothelial cells and macrophages were assayed with TUNEL. Expression of RGS5and adhesion molecules, and ERK1/2 phosphorylation were evaluated by co-staining with CD31. Expression of mRNA and protein were determined by quantitative real-time PCR and Western blotting respectively. Key ResultsAtherosclerotic phenotypes were significantly accelerated in RGS5(-/-)ApoE(-/-) mice, as indicated by increased inflammatory mediator expression and apoptosis of endothelial cells and macrophages. RGS5 deficiency enhanced instability of vulnerable plaques by increasing infiltration of macrophages in parallel with the accumulation of lipids, and decreased smooth muscle cell and collagen content. Mechanistically, increased activation of NF-B and MAPK/ERK 1/2 could be responsible for the accelerated development of atherosclerosis in RGS5-deficient mice. Conclusions and ImplicationsRGS5 deletion accelerated development of atherosclerosis and decreased the stability of atherosclerotic plaques partly through activating NF-B and the MEK-ERK1/2 signalling pathways. Linked ArticlesThis article is part of a themed section on Chinese Innovation in Cardiovascular Drug Discovery. To view the other articles in this section visit http://dx. doi. org/10.1111/bph. 2015.172. issue-23

Regulator of G-protein signaling 5 and cancer research

The Relationship Between RGS5 Expression and Cancer Differentiation and Metastasis in Non‐small Cell Lung Cancer

GPRC5A: an Emerging Biomarker in Human Cancer

RGS5 maintaining vascular homeostasis is altered by the tumor microenvironment

RGS Proteins and Their Roles in Cancer: Friend or Foe?

Regulator of G Protein Signaling 5 Protects Against Cardiac Hypertrophy and Fibrosis During Biomechanical Stress of Pressure Overload

Overexpression of the regulator of G-protein signaling 5 reduces the survival rate and enhances the radiation response of human lung cancer cells.

Relationship Between RGS5 Expression and Differentiation and Angiogenesis of Gastric Carcinoma.

Over-Expression of Regulator of G Protein Signaling 5 Promotes Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells

Regulator of G-protein signaling 4: a novel tumor suppressor with prognostic significance in non-small cell lung cancer.

Relationship between RGS5 expression and the growth of glioma in rats

Transcription of rgs5 in non-small-cell lung carcinoma and its correlation with clinicopathological parameters

Regulator of G-protein signalling 5 deficiency impairs ventricular remodelling after myocardial infarction by promoting NF-κB and MAPK signalling in mice.

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

Exploring the promise of regulator of G Protein Signaling 20: insights into potential mechanisms and prospects across solid cancers and hematological malignancies

Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice.

Unraveling the prognostic significance of RGS gene family in gastric cancer and the potential implication of RGS4 in regulating tumor-infiltrating fibroblast

A regulator of G protein signaling 5 marked subpopulation of vascular smooth muscle cells is lost during vascular disease

RGS5–TGFβ–Smad2/3 axis switches pro- to anti-apoptotic signaling in tumor-residing pericytes, assisting tumor growth

RGS5 Attenuates Baseline Activity of ERK1/2 and Promotes Growth Arrest of Vascular Smooth Muscle Cells

Regulator of G protein signaling 1 is a potential target in gastric cancer and impacts tumor‐associated macrophages